{
    "title": "UPDATE 1-AstraZeneca ticks another box as U.S. approves severe asthma drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5084359/AstraZeneca-ticks-box-U-S-approves-severe-asthma-drug.html",
    "date": "2017-11-15",
    "keywords": [
        "asthma",
        "drug",
        "approval",
        "company",
        "fasenra",
        "cancer",
        "astrazeneca",
        "year",
        "portfolio",
        "treatment",
        "respiratory",
        "medicine",
        "number",
        "blood",
        "hirschler",
        "london",
        "milestone",
        "patent",
        "food",
        "decision",
        "benralizumab",
        "name",
        "recommendation",
        "product",
        "europe",
        "percent",
        "wednesday",
        "news",
        "cinqair",
        "antibody",
        "potency",
        "convenient",
        "dosing",
        "edge",
        "cost",
        "price",
        "maintenance",
        "line",
        "investor",
        "focus",
        "research",
        "history",
        "therapy",
        "earlierstage",
        "tezepelumab",
        "amgen",
        "biotech",
        "hope",
        "case",
        "kind",
        "type",
        "end",
        "fda",
        "addon",
        "series",
        "transformation",
        "executive",
        "soriot",
        "week",
        "drugmaker",
        "execution",
        "mode",
        "success",
        "development",
        "market",
        "lynparza",
        "tagrisso",
        "calquence",
        "month",
        "lung",
        "editing",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}